Epidemiology of metabolic dysfunction-associated steatotic liver diseaseZobair M. Younossi(Inova Health System), Linda Henry(Inova Health System)Clinical and Molecular HepatologyAugust 20, 202410.3350/cmh.2024.0431Cited by 579SaveCiteExport RISWatch citationsRelated PapersA systems biology approach to the pathogenesis of obesity-related nonalcoholic fatty liver disease using reverse phase protein microarrays for multiplexed cell signaling analysis|Hepatology|2007|51